Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
Patents for C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
10/2003
10/28/2003US6638947 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof
10/28/2003US6638927 Melanocortin-4 receptor (MC4-R) agonists; treating obesity or diabetes; 4-((N-cyclohexyl-3,5-dimethyl-piperazine-1-carboximidoyl)-amino)-N-(2-(2,4 -dichlorophenyl) -ethyl)-benzamide for example
10/23/2003WO2003087387A1 Chemo-enzymatic synthesis of optically enriched rose-oxides
10/23/2003WO2003087108A2 Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses
10/23/2003WO2003087040A2 Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses
10/23/2003WO2003007954A3 Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors
10/23/2003WO2002046128A3 Quaternary amino acids on solid supports
10/23/2003WO2001036048A8 Phorboxazole derivatives for treating cancer
10/23/2003US20030199572 Use as pesticides and herbicides
10/23/2003US20030199560 Bisaryl compound and medicament for cancer treatment comprising the same
10/23/2003US20030199499 Novel guanidinobenzamides
10/23/2003US20030199482 Anticholesterol agents; a drug mixture for treating hypercholesterolemia comprising an apical sodium co-dependent bile acid transport inhibitor, enzyme inhibitors of a cyclooxygenase-2
10/23/2003US20030199075 Compactin is provided and contacted with Actinomadura bacteria containing hydroxylase under hydroxylation condition to convert compactin to pravastatin, useful for lowering cholesterol levels in mammals
10/23/2003CA2480415A1 Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses
10/23/2003CA2480410A1 Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses
10/22/2003EP1192122B1 Benzene derivatives, preparation method and pharmaceutical compositions containing same
10/22/2003CN1451000A A process for producing simvastatin
10/21/2003US6635622 Having anti-tumor activity and immunostimulating activity
10/16/2003WO2003084911A1 Process for converting alcohols to carbonyl compounds
10/16/2003WO2003084558A1 Improved kavalactone profile
10/16/2003WO2003084512A1 Oral delivery of a botanical
10/16/2003WO2003051325A8 Skin lightening agents, novel compounds, compositions and use
10/16/2003WO2002100849A3 Novel nitriles useful as reversible inhibitors of cysteine proteases
10/16/2003US20030195239 Heterocyclic esters such as 6-cyclopentyl-6-(4-phenyl-but-3-ynyl)-dihydropyran-2,4-dione, used as enzyme inhibitors or for prophylaxis of virus infections
10/16/2003US20030194785 Making an erythromycin derivative of given formula by fermenting an organism capable of producing erythromycin in the presence of a carboxylic acid of given formula
10/16/2003CA2486480A1 Improved kavalactone profile
10/16/2003CA2480788A1 Process for converting alcohols to carbonyl compounds
10/15/2003EP1351946A2 Materials and methods to potentiate cancer treatment
10/15/2003EP1351916A2 Ether compounds and compositions for cholesterol management and related uses
10/15/2003EP1351909A1 Method and device for the distillative processing of 1,6-hexandiol, 1,5-pentandiol and caprolactone
10/14/2003CA2291994C Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents
10/09/2003WO2003083063A2 Common ligand mimics: naphtoates
10/09/2003WO2003082848A1 Pyranon and pyrandion inhibitors of hepatitis c virus rna-dependent rna polymerase
10/09/2003WO2003082846A1 Anomeric derivatives of monosaccharides
10/09/2003WO2003082808A1 Benzamide derivatives
10/09/2003WO2003082298A1 Statin therapy for enhancing cognitive maintenance
10/09/2003WO2003082190A2 Spirocyclic amides as cannabinoid receptor modulators
10/09/2003US20030191340 Catalytic compositions and methods for asymmetric allylic alkylation
10/09/2003US20030191317 Sulfonyl aryl or heteroaryl hydroxamic acid compounds
10/09/2003US20030191306 Substituted N-Aliphatic-N-Aromatictertiary-Heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
10/09/2003US20030191177 Maintenance dosage of beta blocker; cardiovascular disorders
10/09/2003CA2480578A1 Anomeric derivatives of monosaccharides
10/09/2003CA2479618A1 Spirocyclic amides as cannabinoid receptor modulators
10/08/2003EP1351322A1 Red organic electroluminescent devices
10/08/2003CN1447804A 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat VCAM-1 mediated disorders
10/08/2003CN1447633A Red organic electroluminescent element
10/07/2003US6630594 Spiro-pyran compounds; use as pesticides and herbicides
10/07/2003US6630492 Lymphocyte function antigen-1 antagonists
10/07/2003CA2223418C Polyoxyhydrocarbyl related products and methods for fluorescence assays
10/02/2003WO2003080592A1 2-pyrone compounds and use thereof
10/02/2003WO2003080591A1 Process for the preparation of 4-oxytetrahydropyran-2-ones
10/02/2003WO2003080588A1 Cyclic 1-(acyloxy)-alkyl prodrugs of gaba analogs, compositions and uses thereof
10/02/2003WO2003080553A1 Cyclopentene derivatives
10/02/2003WO2003080053A1 Combination treatments for chemokine-mediated diseases
10/02/2003WO2003079996A2 Process for preparing purified s-bel and r-bel and compositions thereof
10/02/2003WO2003044015A3 Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors
10/02/2003US20030187235 Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
10/02/2003US20030187064 Use
10/02/2003US20030187063 Compounds useful for inhibiting paramyxovirus neuraminidase
10/02/2003US20030186962 Cysteine protease inhibitors
10/02/2003US20030186943 Substituted gamma-phenyl-delta-lactams and uses related thereto
10/01/2003EP1348443A1 Combination drugs
10/01/2003EP1347757A2 Method for detoxifying a carbohydrate containing solution
10/01/2003EP0960095B1 3-aminocarbonyl/3-aminothiocarbonyl-substituted 2-benzoyl- cyclohexan-1,3-diones with herbicidal effect
10/01/2003CN1446208A Process for preparing discodermolid and analogues thereof
10/01/2003CN1446088A Highly purified simvastatin compositions
09/2003
09/30/2003US6627763 Compounds having protected hydroxy groups
09/30/2003US6627651 Exhibiting preventive and therapeutic effects against HIV infectious diseases wherein R1 is an optionally substituted five- or six-membered ring group; X1 is a free valency or the like; W is a divalent group and inhibitors of HIV (human
09/30/2003US6627611 C-glycosides and preparation of thereof as antidiabetic agents
09/30/2003US6627111 Reduced pH sensitivity and enhanced stability to protonation; efficiency
09/25/2003WO2002032842A3 Compounds with high monoamine transporter affinity
09/25/2003WO2002030884A3 Sulfide and disulfide compounds and compositions for cholesterol management and related uses
09/25/2003WO2002030882A3 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
09/25/2003US20030181402 Exotic sugars, artificial sweetener prepared from common monosaccharides, stereoselective transformation
09/24/2003EP1345931A2 Cysteine protease inhibitors
09/24/2003EP1345919A2 Novel c-glycoside derivatives and use thereof
09/24/2003EP0984959B1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
09/24/2003CN1444577A Method for producing 3,4-dihydro-2H-pyran
09/24/2003CN1122029C Process for producing simvastatin
09/23/2003US6624190 Useful as biodegradable surfactants and in enzymatic processes using a chitinase (N-acetylglucosaminidase)
09/23/2003US6624189 Byrostatin analogues, synthetic methods and uses
09/18/2003WO2003076397A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
09/18/2003WO2003076389A1 Compositions and methods for inhibition of phospholipase a2 mediated inflammation
09/18/2003WO2003075853A2 Cyclic derivatives as modulators of chemokine receptor activity
09/18/2003WO2002100323A3 METHYL ANALOGS OF SIMVASTATIN AS NOVEL HMG-CoA REDUCTASE INHIBITORS
09/18/2003US20030176501 For use in inhibiting HMG-CoA reductase; therapy and prophylaxis of hypercholesterolemia, atherosclerotic disease
09/18/2003US20030176464 Phenyl substituted 4-hydroxy tetrahydroxypyridone
09/18/2003CA2479065A1 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
09/18/2003CA2477949A1 Compositions and methods for inhibition of phospholipase a2 mediated inflammation
09/17/2003EP1344109A2 Onium salts and the use therof as latent acids
09/17/2003EP1343751A2 Cyclic derivatives as modulators of chemokine receptor activity
09/17/2003CN1443183A Process for preparation of 2-(6-substituted-1,3-dioxane-4-yl) acetic acid derivatives
09/17/2003CN1443182A Process for purifying lovastatin and simvastatin with reduced levels of dimeric impurities
09/17/2003CN1443181A Phenyl-substituted 5,6-dihydropyrone derivatives for use as pesticides and herbicides
09/17/2003CN1443177A Alpha-acyl and alpha-heteroatom-substituted benzene acetamide glucokinase activators
09/17/2003CN1443160A N-substituted-1-amino-1,1-dialkyl carboxylic acid derivatives
09/17/2003CN1442219A Oscillating device
09/16/2003US6620468 Dioxane derivatives, and liquid-crystalline medium
09/16/2003CA2078519C Process for the preparation of chlorosulfate and sulfamate derivatives of 2,3:4,5-bis-0-(1-methylethylidene)-beta-d-fructopyranose and (1-methylcyclohexyl)methanol
09/16/2003CA2068089C Method and compositions for using non-ionic contrast agents to reduce the risk of clot formulation in diagnostic procedures
1 ... 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 ... 129